These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32151631)

  • 21. Omeprazole-induced subacute cutaneous lupus erythematosus.
    Mankia SK; Rytina E; Burrows NP
    Clin Exp Dermatol; 2010 Apr; 35(3):e1-2. PubMed ID: 20500156
    [No Abstract]   [Full Text] [Related]  

  • 22. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Brooke R; Coulson IH; al-Dawoud A
    Br J Dermatol; 1998 Dec; 139(6):1132-3. PubMed ID: 9990400
    [No Abstract]   [Full Text] [Related]  

  • 23. An uncommon cutaneous reaction for a common drug. Diagnosis: Drug-induced subacute cutaneous lupus erythematosus (DI-SCLE).
    Kwong HL; Teo RY
    Ann Acad Med Singap; 2014 Aug; 43(8):433-4. PubMed ID: 25244994
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumour necrosis factor antagonist-induced lupus: a Critically Appraised Topic.
    Momen SE; Kirkham B; Barker JN; Smith CH
    Br J Dermatol; 2017 Dec; 177(6):1519-1526. PubMed ID: 28771665
    [No Abstract]   [Full Text] [Related]  

  • 25. Subacute cutaneous lupus erythematosus associated with leflunomide.
    Kerr OA; Murray CS; Tidman MJ
    Clin Exp Dermatol; 2004 May; 29(3):319-20. PubMed ID: 15115526
    [No Abstract]   [Full Text] [Related]  

  • 26. Terbinafine as a cause of cutaneous lupus erythematosus.
    McKellar G; Porter D; Burden D
    Rheumatology (Oxford); 2004 Feb; 43(2):249. PubMed ID: 14739471
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous lupus erythematosus induced by drugs - novel insights.
    Borucki R; Werth VP
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):35-42. PubMed ID: 31774327
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic/cutaneous lupus erythematosus patients.
    Kishi C; Motegi SI; Yasuda M; Ishikawa O
    J Dermatol; 2018 Aug; 45(8):1020-1022. PubMed ID: 30133802
    [No Abstract]   [Full Text] [Related]  

  • 29. Subacute cutaneous lupus erythematosus associated with terbinafine.
    Kasperkiewicz M; Anemüller W; Angelova-Fischer I; Rose C; Zillikens D; Fischer TW
    Clin Exp Dermatol; 2009 Oct; 34(7):e403-4. PubMed ID: 19549237
    [No Abstract]   [Full Text] [Related]  

  • 30. Subacute-cutaneous lupus erythematosus induced by Simvastatin.
    Rüger RD; Simon JC; Treudler R
    J Dtsch Dermatol Ges; 2011 Jan; 9(1):54-5. PubMed ID: 21040470
    [No Abstract]   [Full Text] [Related]  

  • 31. Subacute cutaneous lupus erythematosus triggered by an antiviral treatment combination for hepatitis C virus infection.
    Prenner A; Blum R; Beltraminelli H; Stirnimann G; Borradori L
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):e129-e131. PubMed ID: 30394571
    [No Abstract]   [Full Text] [Related]  

  • 32. Terbinafine-induced lupus erythematosus.
    Murphy M; Barnes L
    Br J Dermatol; 1998 Apr; 138(4):708-9. PubMed ID: 9640387
    [No Abstract]   [Full Text] [Related]  

  • 33. Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.
    Mittal L; Zhang L; Feng R; Werth VP
    J Am Acad Dermatol; 2018 Jan; 78(1):100-106.e1. PubMed ID: 28989103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE-inhibitor-induced drug eruption resembling lymphocytic infiltration (of Jessner-Kanof) and Lupus erythematosus tumidus.
    Schepis C; Lentini M; Siragusa M; Batolo D
    Dermatology; 2004; 208(4):354-5. PubMed ID: 15178923
    [No Abstract]   [Full Text] [Related]  

  • 35. Subacute cutaneous lupus erythematosus induced by capecitabine.
    Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
    Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
    [No Abstract]   [Full Text] [Related]  

  • 36. [Subacute cutaneous lupus erythematosus induced by golimumab].
    Blasco-Morente G; Notario-Ferreira I; Rueda-Villafranca B; Tercedor-Sánchez J
    Med Clin (Barc); 2015 Sep; 145(5):226-7. PubMed ID: 25547737
    [No Abstract]   [Full Text] [Related]  

  • 37. Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin.
    Miyagawa S; Okuchi T; Shiomi Y; Sakamoto K
    J Am Acad Dermatol; 1989 Aug; 21(2 Pt 2):343-6. PubMed ID: 2474012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exacerbation of systemic lupus erythematosus induced by terbinafine.
    Holmes S; Kemmett D
    Br J Dermatol; 1998 Dec; 139(6):1133. PubMed ID: 9990401
    [No Abstract]   [Full Text] [Related]  

  • 39. Subacute cutaneous lupus erythematosus induced by the new multikinase inhibitor pazopanib.
    Casado-Verrier B; Pérez-Santos S; Delgado-Mucientes C; Beato-Merino M
    Br J Dermatol; 2014 Dec; 171(6):1559-61. PubMed ID: 24909204
    [No Abstract]   [Full Text] [Related]  

  • 40. Proton pump inhibitors and subacute cutaneous lupus erythematosus: an under-recognized phenomenon?
    Cookson H; Walsh S
    Br J Dermatol; 2014 Feb; 170(2):235. PubMed ID: 24547716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.